Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Marketing Surveillance of Roflumilast in Korea

NCT02068456 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02068456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02068456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Marketing Surveillance of Roflumilast in Korea
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
September 18, 2012
Completion date
April 26, 2017
Enrollment
1,837 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease